Karus Therapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Genesis Building Library Ave, Didcot, Ox...Phone Number
+44 1235829140Website
www.karustherapeutics.comRevenue
<$5 MillionIndustry
About Karus Therapeutics
Is Karus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Karus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Karus Therapeutics launches new products
Click to see if Karus Therapeutics had a recent Job posting/layoffs
Check if Karus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Karus Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Karus Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Karus Therapeutics
Earning: See what the market has to say on Karus Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Karus Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Karus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Karus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Karus Therapeutics.
Karus Therapeutics financials insights
Gather financial insights about Karus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$7.6M
Series A
$7.6M
Karus Therapeutics Tech Stack
A closer look at the technologies used by Karus Therapeutics
Karus Therapeutics News & Media
Karus Therapeutics to Announce Positive New Data from Phase I Relapsed/Refractory B-Cell Lymphoma Trial at ASH
OXFORDSHIRE, England--(BUSINESS WIRE)--Karus Therapeutics will be presenting new data from its KA2237 Phase I study at the ASH Annual Meeting & Exposition in Orlando, Florida, 9 Dec. 2019
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Karus Therapeutics
Founded 2005, Karus Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development of precision medicines to treat cancer patients. Karus Therapeutics is located in the United Kingdom... Read More